Walter Public Investments Inc. Takes Position in Cellebrite DI Ltd. $CLBT

Walter Public Investments Inc. purchased a new stake in Cellebrite DI Ltd. (NASDAQ:CLBT) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 512,615 shares of the company’s stock, valued at approximately $9,242,000. Cellebrite DI makes up 1.6% of Walter Public Investments Inc.’s holdings, making the stock its 29th biggest position. Walter Public Investments Inc. owned 0.21% of Cellebrite DI at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Norwood Investment Partners LP purchased a new stake in Cellebrite DI during the 3rd quarter worth about $4,274,000. TimesSquare Capital Management LLC purchased a new stake in Cellebrite DI during the 3rd quarter worth about $11,217,000. Wisconsin Capital Management LLC purchased a new stake in Cellebrite DI during the 3rd quarter worth about $1,649,000. Granite Investment Partners LLC purchased a new stake in Cellebrite DI during the 3rd quarter worth about $11,406,000. Finally, TD Asset Management Inc increased its position in Cellebrite DI by 52.8% during the 3rd quarter. TD Asset Management Inc now owns 324,241 shares of the company’s stock worth $6,008,000 after purchasing an additional 112,005 shares in the last quarter. Hedge funds and other institutional investors own 45.88% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on CLBT. Needham & Company LLC lowered their price target on Cellebrite DI from $18.00 to $15.00 and set a “buy” rating for the company in a report on Friday, May 15th. Wall Street Zen upgraded Cellebrite DI from a “sell” rating to a “hold” rating in a report on Sunday, March 15th. Weiss Ratings upgraded Cellebrite DI from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, May 18th. Finally, DA Davidson began coverage on Cellebrite DI in a report on Wednesday. They issued a “buy” rating and a $20.00 price target for the company. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $21.40.

Insider Buying and Selling at Cellebrite DI

In other news, CRO Marcus Jewell sold 12,658 shares of Cellebrite DI stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $12.77, for a total value of $161,642.66. Following the transaction, the executive directly owned 440,101 shares of the company’s stock, valued at $5,620,089.77. The trade was a 2.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Over the last quarter, insiders sold 13,269 shares of company stock valued at $169,592. Insiders own 5.70% of the company’s stock.

Cellebrite DI Price Performance

NASDAQ CLBT opened at $14.73 on Friday. The firm has a market capitalization of $3.67 billion, a P/E ratio of 52.61, a P/E/G ratio of 1.76 and a beta of 1.15. Cellebrite DI Ltd. has a 1-year low of $11.02 and a 1-year high of $19.98. The business’s 50-day simple moving average is $13.27 and its 200-day simple moving average is $15.29.

Cellebrite DI Profile

Cellebrite DI is a global provider of digital intelligence and forensics solutions that enable law enforcement agencies, government bodies and enterprises to extract, analyze and act on data from mobile devices, cloud services and digital sources. The company’s technology is designed to accelerate investigations, support evidence-based decision-making and enhance security operations by delivering actionable intelligence in a secure, scalable platform.

The company’s flagship offerings include the Universal Forensic Extraction Device (UFED) series for data acquisition and decoding, Physical Analyzer for advanced data parsing and visualization, and Pathfinder for case-driven investigation workflows.